User profiles for Laurent P. Rivory
Laurent RivoryVerified email at unsw.edu.au Cited by 5971 |
Clinical pharmacokinetics of docetaxel
Docetaxel (Taxotere®), a semi-synthetic analog of paclitaxel (Taxol®), is a promoter of
microtubule polymerization leading to cell cycle arrest at G2/M, apoptosis and cytotoxicity. …
microtubule polymerization leading to cell cycle arrest at G2/M, apoptosis and cytotoxicity. …
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
We have investigated the conversion of the novel anti-topoisomerase I agent CPT-11 (irinotecan;
7-ethyl-10[4-(1-piperidino)-1piperidino]carbonyloxycamptothecin) to its active …
7-ethyl-10[4-(1-piperidino)-1piperidino]carbonyloxycamptothecin) to its active …
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy
An important limitation in the use of chemotherapy in cancer treatment is that cytotoxic
agents have small margins of safety compared with other drugs. The largely unpredictable …
agents have small margins of safety compared with other drugs. The largely unpredictable …
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance
DG Le Couteur, R Fraser, S Kilmer, LP Rivory… - Clinical …, 2005 - Springer
The fenestrated sinusoidal endothelium (‘liver sieve’) and space of Disse in the healthy liver
do not impede the transfer of most substrates, including drugs and oxygen, from the …
do not impede the transfer of most substrates, including drugs and oxygen, from the …
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
Irinotecan (CPT-11) is an analogue of 20(S)-camptothecin with promising activity against
several tumor types. In patients, CPT-11 is metabolized to 7-ethyl-10-hydroxycamptothecin (SN-…
several tumor types. In patients, CPT-11 is metabolized to 7-ethyl-10-hydroxycamptothecin (SN-…
Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy
Depletion of nutritional reserves and significant weight loss can lead to an increased risk of
morbidity, reduced chemotherapy response, and shorter survival in patients with cancer. …
morbidity, reduced chemotherapy response, and shorter survival in patients with cancer. …
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients
R Sharma, JM Hoskins, LP Rivory, M Zucknick… - Clinical cancer …, 2008 - AACR
Purpose: To evaluate the effect of thymidylate synthase (TYMS) and methylenetetrahydrofolate
reductase (MTHFR) genotypes on toxicity in patients treated with capecitabine for …
reductase (MTHFR) genotypes on toxicity in patients treated with capecitabine for …
Factors affecting cytochrome P-450 3A activity in cancer patients
Purpose: The purpose is to identify the demographic, physiologic, and inheritable factors that
influence CYP3A activity in cancer patients Experimental Design: A total of 134 patients (62 …
influence CYP3A activity in cancer patients Experimental Design: A total of 134 patients (62 …
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38
Irinotecan, or CPT-11 (7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine),
is a water-soluble derivative of camptothecine with promising activity against several types …
is a water-soluble derivative of camptothecine with promising activity against several types …
Molecular, cellular, and clinical aspects of the pharmacology of 20 (S) camptothecin and its derivatives
The discovery of the plant alkaloid 20(S)camptothecin (CPT), which displayed potent
antitumor activity in preclinical trials, has led to the identification of a novel target of cancer …
antitumor activity in preclinical trials, has led to the identification of a novel target of cancer …